These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10825999)

  • 1. Viral hepatitis C.
    Leevy CB; Zierer KG; Leevy CM
    J Assoc Acad Minor Phys; 1998; 9(4):59-64. PubMed ID: 10825999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection: an overview.
    Hwang SJ
    J Microbiol Immunol Infect; 2001 Dec; 34(4):227-34. PubMed ID: 11825001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis C.
    Kim AI; Saab S
    Am J Med; 2005 Aug; 118(8):808-15. PubMed ID: 16084169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future therapies for hepatitis C.
    Pawlotsky JM; Gish RG
    Antivir Ther; 2006; 11(4):397-408. PubMed ID: 16856613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic hepatitis].
    Figueroa Barrios R
    Rev Gastroenterol Peru; 1995; 15 Suppl 1():S77-88. PubMed ID: 8520023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C--clinical profile.
    Bhandari B; Pal A
    J Indian Med Assoc; 2007 Aug; 105(8):453-4, 456, 465. PubMed ID: 18236909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C in childhood.
    Sibal A; Mishra D; Arora M
    J Indian Med Assoc; 2002 Feb; 100(2):93-8. PubMed ID: 12206357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C virus and resulting diseases].
    Armas-Merino R; Wolff C; Soto R; Jirón MI; Parraguez A
    Rev Med Chil; 1999 Oct; 127(10):1240-54. PubMed ID: 10835742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular methods of hepatitis C genotyping.
    Weck K
    Expert Rev Mol Diagn; 2005 Jul; 5(4):507-20. PubMed ID: 16013969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subversion of innate host antiviral strategies by the hepatitis C virus.
    Bode JG; Brenndörfer ED; Häussinger D
    Arch Biochem Biophys; 2007 Jun; 462(2):254-65. PubMed ID: 17467654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
    Feld JJ; Hoofnagle JH
    Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.